—
C+
C+ The full Closelooknet — membership. Open the C+ overview

IQVIA Holdings Inc (IQV) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for IQV, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
How it trades on rate days beta 0.50 to TLT · on the worst bond days it held up better than the market

How it trades on rate days

How IQV has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.50 — shows only a loose link to bond moves for every 1% move in TLT (20+ year Treasuries), IQVIA Holdings Inc moved 0.50% on average · correlation 0.11 · higher than 52% of US names
  • Beta, last 3 months 0.49 about the same as over the year
  • On the 10 worst bond days +0.07% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +2.67% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Diagnostics & Research · United States · 8 names with week and year-to-date

Peer group

Diagnostics & Research · United States

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against IQV on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — IQVIA Holdings Inc

IQV in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
IQVIA supplies clinical trial services, commercial data and healthcare intelligence to life sciences and healthcare companies worldwide. It runs three segments: Technology & Analytics Solutions for cloud-based data and real-world evidence tools, Research & Development Solutions for running and supporting clinical trials and laboratory work, and Contract Sales & Medical Solutions for patient and provider engagement on behalf of clients. Its customers are pharmaceutical, biotechnology, device, diagnostic and consumer-health companies. It is headquartered in Durham, United States.
Where it sits in the stack
IQVIA holds no seat in Rubin, our index for the AI build-out. It sits in our universe's healthcare sleeve, under diagnostics and research, as a services and data provider that pharmaceutical and biotech companies use to run trials and read commercial markets.
Who it is priced against
The diary has not built a peer group for IQVIA. The name the market most often compares it with is ICON plc, another contract research organisation offering similar clinical-trial and laboratory services.
Why Closelooknet tracks it
IQVIA carries no Closelooknet score and no Rubin seat. The only index tag the diary holds for it is a place in the S&P 500.
What the diary watches
The diary watches whether pharmaceutical clients keep outsourcing clinical trial and commercial-data work at the same pace, since that flow moves the balance across IQVIA's three segments.

IQVIA Holdings Inc (IQV) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

FAQ · from the current data · as of 2026-09-26

Quick answers

What is IQVIA Holdings Inc (IQV)?

IQVIA Holdings Inc trades as IQV on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is IQV in a Closelooknet index?

Not currently — IQVIA Holdings Inc is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-09-26.

Where does IQV trade against its moving averages?

Uptrend stack intact: Trades +9.2% vs the 50-day and +32% vs the 200-day average, 2.5% below the 52-week high and +75% off the 52-week low; a golden cross printed 36 sessions ago. Computed from daily closes. As of 2026-09-25 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does IQVIA Holdings Inc trade when bond yields rise?

Over the past year IQVIA Holdings Inc had a beta of 0.50 to TLT, the long-dated Treasury fund — it shows only a loose link to bond moves, higher than 52% of US names. On the 10 sessions in which long bonds fell most it moved +0.07% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does IQVIA Holdings Inc do?

IQVIA supplies clinical trial services, commercial data and healthcare intelligence to life sciences and healthcare companies worldwide. It runs three segments: Technology & Analytics Solutions for cloud-based data and real-world evidence tools, Research & Development Solutions for running and supporting clinical trials and laboratory work, and Contract Sales & Medical Solutions for patient and provider engagement on behalf of clients. Its customers are pharmaceutical, biotechnology, device, diagnostic and consumer-health companies. The diary has not built a peer group for IQVIA. The name the market most often compares it with is ICON plc, another contract research organisation offering similar clinical-trial and laboratory services.

Where does IQVIA Holdings Inc sit in the AI build-out?

IQVIA holds no seat in Rubin, our index for the AI build-out. It sits in our universe's healthcare sleeve, under diagnostics and research, as a services and data provider that pharmaceutical and biotech companies use to run trials and read commercial markets. IQVIA carries no Closelooknet score and no Rubin seat. The only index tag the diary holds for it is a place in the S&P 500.

What does this page show?

A live price chart with SMA overlays and drawing tools for IQV, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Diagnostics & Research. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.